Stimvia
PrivateLast Round
Series A
Sep 18, 2023
Company Overview
Stimvia is a medical technology company that develops non-invasive neuromodulation systems for the treatment of chronic diseases such as overactive bladder and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stimvia Comparables
Compare Stimvia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EBT Medical | 90% | |
| Stimuli Technology | 82% | |
| Avation Medical | 78% | |
Stimvia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 18, 2023 | ||||
| VC Round | Jun 1, 2021 | ||||
| Angel | Jul 7, 2014 |
Stimvia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purple Ventures | VC Round |
| Soulmates Ventures | VC Round |
| Climate KIC | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2021
$4.6M round led by Purple Ventures and Soulmates Ventures.
Stimvia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stimvia's valuation, stock price, and market status.